Literature DB >> 33910949

Vaccinia Virus Gene Acquisition through Nonhomologous Recombination.

Greg Vallée1,2, Peter Norris1,2, Patrick Paszkowski1,2, Ryan S Noyce1,2, David H Evans1,2.   

Abstract

Many of the genes encoded by poxviruses are orthologs of cellular genes. These virus genes serve different purposes, but perhaps of most interest is the way some have been repurposed to inhibit the antiviral pathways that their cellular homologs still regulate. What is unclear is how these virus genes were acquired, although it is presumed to have been catalyzed by some form(s) of nonhomologous recombination (NHR). We used transfection assays and substrates encoding a fluorescent and drug-selectable marker to examine the NHR frequency in vaccinia virus (VAC)-infected cells. These studies showed that when cells were transfected with linear duplex DNAs bearing VAC N2L gene homology, it yielded a recombinant frequency (RF) of 6.7 × 10-4. In contrast, DNA lacking any VAC homology reduced the yield of recombinants ∼400-fold (RF = 1.6 × 10-6). DNA-RNA hybrids were also substrates, although homologous molecules yielded fewer recombinants (RF = 2.1 × 10-5), and nonhomologous substrates yielded only rare recombinants (RF ≤ 3 × 10-8). NHR was associated with genome rearrangements ranging from simple insertions with flanking sequence duplications to large-scale indels that produced helper-dependent viruses. The insert was often also partially duplicated and would rapidly rearrange through homologous recombination. Most of the virus-insert junctions exhibited little or no preexiting microhomology, although a few encoded VAC topoisomerase recognition sites (C/T·CCTT). These studies show that VAC can catalyze NHR through a process that may reflect a form of aberrant replication fork repair. Although it is less efficient than classical homologous recombination, the rates of NHR may still be high enough to drive virus evolution. IMPORTANCE Large DNA viruses sometimes interfere in antiviral defenses using repurposed and mutant forms of the cellular proteins that mediate these same reactions. Such virus orthologs of cellular genes were presumably captured through nonhomologous recombination, perhaps in the distant past, but nothing is known about the processes that might promote "gene capture" or even how often these events occur over the course of an infectious cycle. This study shows that nonhomologous recombination in vaccinia virus-infected cells is frequent enough to seed a small but still significant portion of novel recombinants into large populations of newly replicated virus particles. This offers a route by which a pool of virus might survey the host genome for sequences that offer a selective growth advantage and potentially drive discontinuous virus evolution (saltation) through the acquisition of adventitious traits.

Entities:  

Keywords:  genetic recombination; nonhomologous recombination; saltation; topoisomerase I; vaccinia virus; virus evolution

Mesh:

Substances:

Year:  2021        PMID: 33910949      PMCID: PMC8223923          DOI: 10.1128/JVI.00318-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Amplification of the ribonucleotide reductase small subunit gene: analysis of novel joints and the mechanism of gene duplication in vaccinia virus.

Authors:  M B Slabaugh; N A Roseman; C K Mathews
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

2.  Novel approach to molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase.

Authors:  S Shuman
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

3.  In vitro concatemer formation catalyzed by vaccinia virus DNA polymerase.

Authors:  D O Willer; X D Yao; M J Mann; D H Evans
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

4.  Vaccinia virus: a selectable eukaryotic cloning and expression vector.

Authors:  M Mackett; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

5.  Biogenesis of poxviruses: mirror-image deletions in vaccinia virus DNA.

Authors:  G McFadden; S Dales
Journal:  Cell       Date:  1979-09       Impact factor: 41.582

6.  A selectable and excisable marker system for the rapid creation of recombinant poxviruses.

Authors:  Julia L Rintoul; Jiahu Wang; Don B Gammon; Nicholas J van Buuren; Kenneth Garson; Karen Jardine; Michele Barry; David H Evans; John C Bell
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

7.  Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease.

Authors:  Eric M Mucker; Jennifer Chapman; Louis M Huzella; John W Huggins; Joshua Shamblin; Camenzind G Robinson; Lisa E Hensley
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

8.  Long read sequencing reveals poxvirus evolution through rapid homogenization of gene arrays.

Authors:  Thomas A Sasani; Kelsey R Cone; Aaron R Quinlan; Nels C Elde
Journal:  Elife       Date:  2018-08-29       Impact factor: 8.140

9.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937

10.  Live-Cell Imaging of Vaccinia Virus Recombination.

Authors:  Patrick Paszkowski; Ryan S Noyce; David H Evans
Journal:  PLoS Pathog       Date:  2016-08-15       Impact factor: 6.823

View more
  2 in total

Review 1.  Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug Discovery.

Authors:  Lee R Wright; Dennis L Wright; Sandra K Weller
Journal:  Viruses       Date:  2022-07-16       Impact factor: 5.818

Review 2.  Poxvirus Recombination.

Authors:  David Hugh Evans
Journal:  Pathogens       Date:  2022-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.